Answers are grounded in this paper and cite their sources.
In vivo analysis reveals FOS-diet enhances CAR T cell activity in myeloma, indicating survival improvements.
Supplementary Figure S11 demonstrates the in vivo effects of a FOS-diet on CAR T cells using an ARP-1 mouse model. This figure presents a schematic of the experimental setup, analyzes absolute peripheral blood CD4+ and CD8+ T-cell counts at various time points post-infusion, tracks tumor growth kinetics via bioluminescent imaging, and provides a Kaplan-Meier survival curve for treated mice.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: